CN204275065U - Xiaoyin effervescent tablet - Google Patents
Xiaoyin effervescent tablet Download PDFInfo
- Publication number
- CN204275065U CN204275065U CN201420713338.7U CN201420713338U CN204275065U CN 204275065 U CN204275065 U CN 204275065U CN 201420713338 U CN201420713338 U CN 201420713338U CN 204275065 U CN204275065 U CN 204275065U
- Authority
- CN
- China
- Prior art keywords
- xiaoyin
- acid source
- effervescent tablet
- layer
- capsule skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000009509 xiaoyin Substances 0.000 title claims abstract description 87
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 51
- 239000002253 acid Substances 0.000 claims abstract description 66
- 239000002775 capsule Substances 0.000 claims abstract description 51
- 239000003513 alkali Substances 0.000 claims abstract description 41
- 239000008187 granular material Substances 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 19
- 238000010521 absorption reaction Methods 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 4
- 239000004005 microsphere Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000013268 sustained release Methods 0.000 claims description 3
- 239000012730 sustained-release form Substances 0.000 claims description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model discloses a kind of Xiaoyin effervescent tablet, comprise acid source layer, Xiaoyin medicine layer and alkali source layer from inside to outside successively, described acid source layer comprises acid source utricule; Acid source utricule comprises the first capsule skin of acid source and parcel acid source; First capsule Intradermal is filled with alkali source granule.Xiaoyin effervescent tablet of the present utility model, stable in properties, can not affect the stability of effervescent tablet because of the acid source moisture absorption; When needs effervescent, rate of effervescence is fast; Energy secondary effervescent, effervescent is abundant.
Description
Technical field
This utility model belongs to drug world, particularly a kind of Xiaoyin effervescent tablet.
Technical background
The primary efficacy that Xiaoyin is clear is clearing away heat and cooling blood, blood enriching and dryness moistening, dispelling wind for relieving itching, and its preparation has XIAOYIN PIAN, Xiaoyin capsule etc. at present.There is the not good problem of taste in oral formulations.Effervescent tablet can solve the problem of existing preparation well, onset is rapid, bioavailability is high, and mouthfeel is good, be particularly suitable for child, old people garment is used, but find no precedent Xiaoyin being made effervescent tablet in prior art, and most of effervescent tablet due to the acid source easy moisture absorption, quality is unstable.In order to solve the problem of the easy moisture absorption of acid source, be generally adopt soda acid to granulate respectively, remix tabletting after soda acid granule, object reduces the contact area of soda acid granule, improves the stability of sample; But the sample stability of preparation is still not high like this.
Utility model content
The purpose of this utility model is to provide and a kind ofly effectively can solves the easy moisture absorption of acid source and cause the Xiaoyin effervescent tablet of the problem of effervescent tablet instability.
Specific description is done to content of the present utility model below:
Xiaoyin effervescent tablet of the present utility model, Xiaoyin effervescent tablet comprises acid source layer, Xiaoyin medicine layer and alkali source layer from inside to outside successively, and described acid source layer comprises acid source utricule; Acid source utricule comprises the first capsule skin of acid source and parcel acid source; First capsule Intradermal is filled with alkali source granule.
Acid source layer is arranged on innermost layer, prevents its moisture absorption; Be wrapped in by acid source in the first capsule skin, alkali source is particles filled in the first capsule Intradermal simultaneously, by soda acid source material separately, when needing effervescent, acid source is easy to mix with alkali source material and effervescent, can realize the effect of secondary effervescent, reach good effervescent effect.
Xiaoyin effervescent tablet of the present utility model, is also provided with the second capsule skin between acid source layer and Xiaoyin medicine layer, the second capsule Intradermal is filled with moisture absorption granule.
The setting of moisture absorption granule in second capsule skin, can stop the moisture absorption of soda acid source material further, ensures the stability of Xiaoyin effervescent tablet.
Xiaoyin effervescent tablet of the present utility model, is also provided with the 3rd capsule skin between Xiaoyin medicine layer and alkali source layer; Acid source granule is filled with in 3rd capsule skin.
The setting of acid source granule in 3rd capsule skin, can act on mutually with alkali source layer, and form an effervescent, rate of effervescence is fast.
Xiaoyin effervescent tablet of the present utility model, Xiaoyin medicine layer is eight flap-type structures, and two adjacent lobes are filled with Xiaoyin utricule and Xiaoyin granule respectively, and Xiaoyin utricule is the utricule being filled with Xiaoyin liquid; Xiaoyin granule is slow-release micro-pill or sustained-release micro-spheres.
Eight flap-type structures improve the contact area of acid source layer and alkali source layer, after effervescent, make it disperse evenly, be filled with Xiaoyin liquid in Xiaoyin utricule, can absorb fast, rapid-onset; Xiaoyin granule plays the effect of slow release.
Xiaoyin effervescent tablet of the present utility model, the 3rd capsule skin is provided with equally distributed groove.
The setting of groove, when needs effervescent, can accelerate rate of effervescence, makes effervescent tablet quick acting further.
Xiaoyin effervescent tablet of the present utility model, alkali source layer comprises alkali source material and the 4th capsule skin, and alkali source material is filled in groove, and the 4th capsule suitcase is wrapped in the skin of the 3rd capsule skin and is fixed the alkali source material be filled in groove.
Alkali source layer be arranged on outermost layer serve in and the effect of gastric acid, can available protecting stomach; Also itself and acid source are separated simultaneously, improve Xiaoyin effervescent tablet stability; The alkali source material of alkali source layer can play the effect of first time effervescent with the acid source granule in the 3rd capsule skin.
The beneficial effect of Xiaoyin effervescent tablet of the present utility model is: Xiaoyin effervescent tablet of the present utility model, stable in properties, can not affect the stability of effervescent tablet because of the acid source moisture absorption; When needs effervescent, rate of effervescence is fast, can secondary effervescent, and effervescent is abundant.
Accompanying drawing explanation
Fig. 1 is the perspective view of Xiaoyin effervescent tablet of the present utility model;
Fig. 2 is the A-A profile of Xiaoyin effervescent tablet in embodiment 1;
Fig. 3 is the A-A profile of Xiaoyin effervescent tablet in embodiment 2;
Fig. 4 is the A-A profile of Xiaoyin effervescent tablet in embodiment 3;
Fig. 5 is the A-A profile of Xiaoyin effervescent tablet in embodiment 4;
Fig. 6 is the A-A profile of Xiaoyin effervescent tablet in embodiment 5.
Detailed description of the invention
Below in conjunction with embodiment, the utility model is described in further detail:
Embodiment 1
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1, 2,1 is acid source layer, and 11 is acid source utricule, and 111 is acid source, and 112 is the first capsule skin, and 113 is alkali source granule; 2 is Xiaoyin medicine layer; 3 is alkali source layer.
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1, 2, Xiaoyin effervescent tablet comprises acid source layer 1, Xiaoyin medicine layer 2 and alkali source layer 3 from inside to outside successively, and acid source layer 1 comprises acid source utricule 11; Acid source utricule 11 comprises the first capsule skin 112 of acid source 111 and parcel acid source; Alkali source granule 113 is filled with in first capsule skin 112.
Embodiment 2
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1,3,1 is acid source layer, and 11 is acid source utricule, and 111 is acid source, and 112 is the first capsule skin, and 113 is alkali source granule; 2 is Xiaoyin medicine layer; 3 is alkali source layer; 4 is the second capsule skin; 41 is moisture absorption granule.
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1,3, except from embodiment 1 exist following different except, all the other are all identical: be also provided with between acid source layer 1 and Xiaoyin medicine layer 2 in second capsule skin 4, second capsule skin 4 and be filled with moisture absorption granule 41.
Embodiment 3
Xiaoyin effervescent tablet of the present utility model, as shown in Fig. 1,4,1 is acid source layer, and 11 is acid source utricule, and 111 is acid source, and 112 is the first capsule skin, and 113 is alkali source granule; 2 is Xiaoyin medicine layer; 3 is alkali source layer; 4 is the second capsule skin; 41 is moisture absorption granule; 5 is the 3rd capsule skin, and 51 is acid source granule.
Xiaoyin effervescent tablet of the present utility model, as shown in Fig. 1,4, except from embodiment 2 exist following different except, all the other are all identical: be also provided with the 3rd capsule skin 5 between Xiaoyin medicine layer 2 and alkali source layer 3; Acid source granule 51 is filled with in 3rd capsule skin 5.
Embodiment 4
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1,5,1 is acid source layer, and 11 is acid source utricule, and 111 is acid source, and 112 is the first capsule skin, and 113 is alkali source granule; 2 is Xiaoyin medicine layer, and 21 is Xiaoyin utricule, and 22 is Xiaoyin granule; 3 is alkali source layer; 4 is the second capsule skin; 41 is moisture absorption granule; 5 is the 3rd capsule skin, and 51 is acid source granule.
Xiaoyin effervescent tablet of the present utility model, as shown in Figure 1,5, except from embodiment 3 exist following different except, all the other are all identical: Xiaoyin medicine layer 2 is eight flap-type structures, two adjacent lobes are filled with Xiaoyin utricule 21 and Xiaoyin granule 22 respectively, and Xiaoyin utricule 21 is for being filled with the utricule of Xiaoyin liquid; Xiaoyin granule 22 is slow-release micro-pill or sustained-release micro-spheres.
Embodiment 5
Xiaoyin effervescent tablet of the present utility model, as a shown in Figure 6,1 is acid source layer, and 11 is acid source utricule, and 111 is acid source, and 112 is the first capsule skin, and 113 is alkali source granule; 2 is Xiaoyin medicine layer, and 21 is Xiaoyin utricule, and 22 is Xiaoyin granule; 3 is alkali source layer, and 31 is alkali source material, and 32 is the 4th capsule skin; 4 is the second capsule skin; 41 is moisture absorption granule; 5 is the 3rd capsule skin, and 51 is acid source granule.
Xiaoyin effervescent tablet of the present utility model, as a shown in Figure 6, except from embodiment 4 exist following different except, all the other are all identical: the 3rd capsule skin 5 is provided with equally distributed groove; Alkali source layer 3 comprises alkali source material 31 and the 4th capsule skin 32, and alkali source material 31 is filled in groove, and the 4th capsule skin 32 is wrapped in the skin of the 3rd capsule skin 5 and is fixed the alkali source material 31 be filled in groove.
The beneficial effect of Xiaoyin effervescent tablet of the present utility model is: Xiaoyin effervescent tablet of the present utility model, stable in properties, can not affect the stability of effervescent tablet because of the acid source moisture absorption; When needs effervescent, rate of effervescence is fast; Energy secondary effervescent, effervescent is abundant.
Claims (6)
1. an Xiaoyin effervescent tablet, it is characterized in that, described Xiaoyin effervescent tablet comprises acid source layer (1), Xiaoyin medicine layer (2) and alkali source layer (3) from inside to outside successively, and described acid source layer (1) comprises acid source utricule (11); Described acid source utricule (11) comprises the first capsule skin (112) of acid source (111) and parcel acid source; Alkali source granule (113) is filled with in described first capsule skin (112).
2. Xiaoyin effervescent tablet according to claim 1, it is characterized in that, also be provided with the second capsule skin (4) between described acid source layer (1) and Xiaoyin medicine layer (2), in described second capsule skin (4), be filled with moisture absorption granule (41).
3. Xiaoyin effervescent tablet according to claim 2, is characterized in that, is also provided with the 3rd capsule skin (5) between described Xiaoyin medicine layer (2) and alkali source layer (3); Acid source granule (51) is filled with in described 3rd capsule skin (5).
4. Xiaoyin effervescent tablet according to claim 3, it is characterized in that, described Xiaoyin medicine layer (2) is eight flap-type structures, two adjacent lobes are filled with Xiaoyin utricule (21) and Xiaoyin granule (22) respectively, and described Xiaoyin utricule (21) is for being filled with the utricule of Xiaoyin liquid; Described Xiaoyin granule (22) is slow-release micro-pill or sustained-release micro-spheres.
5. Xiaoyin effervescent tablet according to claim 4, is characterized in that, described 3rd capsule skin (5) is provided with equally distributed groove.
6. Xiaoyin effervescent tablet according to claim 5, it is characterized in that, described alkali source layer (3) comprises alkali source material (31) and the 4th capsule skin (32), described alkali source material (31) is filled in described groove, and described 4th capsule skin (32) is wrapped in the skin of described 3rd capsule skin (5) and is fixed the alkali source material (31) be filled in described groove.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420713338.7U CN204275065U (en) | 2014-11-24 | 2014-11-24 | Xiaoyin effervescent tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420713338.7U CN204275065U (en) | 2014-11-24 | 2014-11-24 | Xiaoyin effervescent tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204275065U true CN204275065U (en) | 2015-04-22 |
Family
ID=52858271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420713338.7U Expired - Fee Related CN204275065U (en) | 2014-11-24 | 2014-11-24 | Xiaoyin effervescent tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204275065U (en) |
-
2014
- 2014-11-24 CN CN201420713338.7U patent/CN204275065U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652927B (en) | A kind of agate coffee dispersing tablet and preparation method thereof and application | |
| CN103829118A (en) | Chewable tablet containing wall-broken bee pollen, and its preparation method | |
| CN101167807B (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis and its preparing process | |
| CN103784487A (en) | Ginseng micro-powder tablet and preparation method thereof | |
| CN1215861C (en) | Xiasangju effervescent tablet and its preparation process | |
| CN103271208A (en) | Lollipop with functions of clearing heat, moistening lung and strengthening teeth | |
| CN103356881A (en) | Qi-invigorating and blood-nourishing chewing tablets and preparation method thereof | |
| CN101007071A (en) | Traditional Chinese medicine for treating acute and chronic gastroenteritis and bacterial dysentery and its processing technology | |
| CN105995585A (en) | Peony and donkey-hide gelatin health-care food | |
| CN204275065U (en) | Xiaoyin effervescent tablet | |
| CN204275064U (en) | Urapidil effervescent tablet | |
| CN204275066U (en) | Doxofylline effervescent tablet | |
| CN102742695B (en) | Myrsinaceae health-care tea | |
| CN202699427U (en) | Cool and refreshing sanitary towel | |
| CN104435132A (en) | Double-coptis effervescent tablets | |
| CN103816189A (en) | New micronized Cordyceps sinensis tablet and preparation method thereof | |
| CN103535485A (en) | Formula and production method of chrysanthemum heart-fire-clearing tea | |
| CN102836284A (en) | Locust medicinal liquor | |
| CN204246530U (en) | Azithromycin effervescent tablet | |
| CN105495595A (en) | Pearl containing buccal tablets and preparation method | |
| CN106578812A (en) | Solid health-caring beverage and preparation method of same | |
| CN204364476U (en) | Ambroxol effervescent tablet | |
| CN1742956A (en) | Lonicera and Forsythia effervescent tablet for relieving internal heat or fever of humanbody | |
| CN205093528U (en) | Take three -layer honey tablet of diplopore | |
| CN101756086A (en) | Chrysanthemum royal jelly and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20171124 |